LS6 Stock Overview
Clinical Laserthermia Systems AB (publ) engages in the development of treatment tools for diseased tissue under the TRANBERG brand in Sweden.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Clinical Laserthermia Systems AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | kr0.30 |
| 52 Week High | kr24.40 |
| 52 Week Low | kr0.04 |
| Beta | 0.48 |
| 1 Month Change | 7.14% |
| 3 Month Change | -71.15% |
| 1 Year Change | -97.98% |
| 3 Year Change | -99.60% |
| 5 Year Change | -99.84% |
| Change since IPO | -99.81% |
Recent News & Updates
Recent updates
Shareholder Returns
| LS6 | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | -40.0% | 2.1% | 0.5% |
| 1Y | -98.0% | -8.4% | 1.3% |
Return vs Industry: LS6 underperformed the German Medical Equipment industry which returned -7.7% over the past year.
Return vs Market: LS6 underperformed the German Market which returned 2.3% over the past year.
Price Volatility
| LS6 volatility | |
|---|---|
| LS6 Average Weekly Movement | 352.4% |
| Medical Equipment Industry Average Movement | 4.7% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.2% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: LS6's share price has been volatile over the past 3 months.
Volatility Over Time: LS6's weekly volatility has decreased from 1667% to 352% over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2006 | 14 | Dan Mogren | www.clinicallaser.se |
Clinical Laserthermia Systems AB (publ) engages in the development of treatment tools for diseased tissue under the TRANBERG brand in Sweden. The company offers TRANBERG, a thermal therapy system designed to deliver laser energy to heat the target tissue. It also provides mobile laser unit, a controlling component with a wavelength of 1064 nanometers provides multiple options to control treatment.
Clinical Laserthermia Systems AB (publ) Fundamentals Summary
| LS6 fundamental statistics | |
|---|---|
| Market cap | €2.46b |
| Earnings (TTM) | -€6.83m |
| Revenue (TTM) | €708.37k |
3,479x
P/S Ratio-360.7x
P/E RatioIs LS6 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| LS6 income statement (TTM) | |
|---|---|
| Revenue | kr8.27m |
| Cost of Revenue | kr5.28m |
| Gross Profit | kr3.00m |
| Other Expenses | kr82.79m |
| Earnings | -kr79.79m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 17, 2024
| Earnings per share (EPS) | -0.051 |
| Gross Margin | 36.23% |
| Net Profit Margin | -964.49% |
| Debt/Equity Ratio | 0% |
How did LS6 perform over the long term?
See historical performance and comparison